Multiple Manufacturers

ALKERAN

Manufacturer:

Multiple Manufacturers

Alkeran HCPCS:

J9245

HCPCS Code Descriptor:

Injection, melphalan hydrochloride, not otherwise specified, 50 mg

Category:

J Code

Alkeran NDCs:

45963-0686-02, 25021-0221-60, 67457-0215-01, 67457-0195-01, 67457-0579-01, 52609-3001-00, 43598-0392-48, 70700-0278-97, 70860-0214-61, 43598-0027-48, 72266-0128-01, 71288-0132-90, 63323-0760-20, 54288-0109-02

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

25021-0221-60, 67457-0579-01, 52609-3001-00, 70700-0278-97, 70860-0214-61, 43598-0027-48, 72266-0128-01, 54288-0109-02

About Alkeran:

ALKERAN is an Oncology drug manufactured by ApoPharma and administered via the Intravenous route of administration. The J Code: J9245 is aligned to the drug ALKERAN.

ACCESS PRICING AND MORE BY REGISTERING

J9245 Added Date:

January 1, 1995

J9245 Effective Date:

July 1, 2020

J9245 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Alkeran billing and coding information.
Our team did not identify a source for Alkeran patient assistance information. Please reach out to our team if you feel that this is a mistake.
ALKERAN prescribing information can be found at the link below:
Information regarding ALKERAN’s side effects can be found at MedlinePlus